# Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

> **NCT02003014** · — · COMPLETED · sponsor: **Takeda** · enrollment: 899 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT02003014
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 899 (ACTUAL)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02003014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02003014, "Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02003014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*